103 related articles for article (PubMed ID: 10580961)
1. Size of colorectal liver metastases at abdominal CT: comparison of precontrast and postcontrast studies.
Nazarian LN; Park JH; Halpern EJ; Parker L; Johnson PT; Lev-Toaff AS; Wechsler RJ
Radiology; 1999 Dec; 213(3):825-30. PubMed ID: 10580961
[TBL] [Abstract][Full Text] [Related]
2. Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases.
Park JH; Nazarian LN; Halpern EJ; Feld RI; Lev-Toaff AS; Parker L; Wechsler RJ
Acad Radiol; 2001 Aug; 8(8):698-704. PubMed ID: 11508748
[TBL] [Abstract][Full Text] [Related]
3. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols.
Leggett DA; Kelley BB; Bunce IH; Miles KA
Radiology; 1997 Dec; 205(3):716-20. PubMed ID: 9393526
[TBL] [Abstract][Full Text] [Related]
5. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
[TBL] [Abstract][Full Text] [Related]
7. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings.
Scott DJ; Guthrie JA; Arnold P; Ward J; Atchley J; Wilson D; Robinson PJ
Clin Radiol; 2001 Mar; 56(3):235-42. PubMed ID: 11247703
[TBL] [Abstract][Full Text] [Related]
8. Liver lesions: improved detection with dual-detector-array CT and routine 2.5-mm thin collimation.
Weg N; Scheer MR; Gabor MP
Radiology; 1998 Nov; 209(2):417-26. PubMed ID: 9807568
[TBL] [Abstract][Full Text] [Related]
9. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
[TBL] [Abstract][Full Text] [Related]
10. Conspicuity of hepatic metastases on helical CT: effect of different time delays between contrast administration and scanning.
Silverman PM; O'Malley J; Tefft MC; Cooper C; Zeman RK
AJR Am J Roentgenol; 1995 Mar; 164(3):619-23. PubMed ID: 7863882
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
Burgener FA; Hamlin DJ
AJR Am J Roentgenol; 1983 Feb; 140(2):291-5. PubMed ID: 6600346
[TBL] [Abstract][Full Text] [Related]
12. Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.
Badiee S; Franc BL; Webb EM; Chu B; Hawkins RA; Coakley F; Singer L
AJR Am J Roentgenol; 2008 Nov; 191(5):1436-9. PubMed ID: 18941082
[TBL] [Abstract][Full Text] [Related]
13. Liver metastases from melanoma: detection with multiphasic contrast-enhanced CT.
Blake SP; Weisinger K; Atkins MB; Raptopoulos V
Radiology; 1999 Oct; 213(1):92-6. PubMed ID: 10540646
[TBL] [Abstract][Full Text] [Related]
14. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
[TBL] [Abstract][Full Text] [Related]
15. Increased detectability of liver metastases by the use of contrast enhancement in computed tomography. A comparison between the precontrast, the immediate postcontrast and the one hour postcontrast scan.
Sager EM; Scheel B; Talle K
Acta Radiol Diagn (Stockh); 1985; 26(4):369-72. PubMed ID: 3901677
[TBL] [Abstract][Full Text] [Related]
16. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better?
Haider MA; Amitai MM; Rappaport DC; O'Malley ME; Hanbidge AE; Redston M; Lockwood GA; Gallinger S
Radiology; 2002 Oct; 225(1):137-42. PubMed ID: 12354997
[TBL] [Abstract][Full Text] [Related]
17. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times.
Herts BR; Paushter DM; Einstein DM; Zepp R; Friedman RA; Obuchowski N
AJR Am J Roentgenol; 1995 Feb; 164(2):327-31. PubMed ID: 7839963
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.
Baron RL; Oliver JH; Dodd GD; Nalesnik M; Holbert BL; Carr B
Radiology; 1996 May; 199(2):505-11. PubMed ID: 8668803
[TBL] [Abstract][Full Text] [Related]
19. CT arterial portography of the abdomen: effect of injecting papaverine into the mesenteric artery on hepatic contrast enhancement.
Soyer P; Lacheheb D; Levesque M
AJR Am J Roentgenol; 1993 Jun; 160(6):1213-5. PubMed ID: 8498218
[TBL] [Abstract][Full Text] [Related]
20. [CT arterioportography in the spiral technic for the demonstration of liver metastases].
Helmberger H; Bautz W; Vogel U; Lenz M
Rofo; 1993 May; 158(5):410-5. PubMed ID: 8490148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
